[Immunology in clinical practice. VII. Psoriasis].

A new hypothesis of the pathogenesis of psoriasis holds that psoriasis is an epidermal hyperproliferative disorder resulting from abnormal interaction between T cells and basal layer stem cell keratinocytes. New therapies aimed at reducing T cell activity are most successful, as exemplified by the efficacy of systemic cyclosporine in severe cases of psoriasis. New developments in immunogenetics and immunodermatology are anticipated and it is expected that they will fully explain the chain of pathological events.
AuthorsJ D Bos, M A de Rie
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 141 Issue 48 Pg. 2334-8 (Nov 29 1997) ISSN: 0028-2162 [Print] NETHERLANDS
Vernacular TitleImmunologie in de medische praktijk. VII. Psoriasis.
PMID9550823 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Cyclosporins
  • Immunosuppressive Agents
  • Immunotoxins
  • Antibodies, Monoclonal (therapeutic use)
  • Cyclosporins (therapeutic use)
  • Humans
  • Immunogenetics
  • Immunosuppressive Agents (therapeutic use)
  • Immunotherapy (methods)
  • Immunotoxins (therapeutic use)
  • Keratinocytes (immunology)
  • Psoriasis (immunology, pathology, therapy)
  • Stem Cells (immunology)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: